ID22645A - Modifikasi terbaru untuk 2-amino-4-(4-fluorobenzilamino)-1-etoksikarbonil-aminobenzena dan proses-proses untuk membuat senyawa tersebut - Google Patents

Modifikasi terbaru untuk 2-amino-4-(4-fluorobenzilamino)-1-etoksikarbonil-aminobenzena dan proses-proses untuk membuat senyawa tersebut

Info

Publication number
ID22645A
ID22645A IDW990520A ID990520A ID22645A ID 22645 A ID22645 A ID 22645A ID W990520 A IDW990520 A ID W990520A ID 990520 A ID990520 A ID 990520A ID 22645 A ID22645 A ID 22645A
Authority
ID
Indonesia
Prior art keywords
fluorobenzilamino
ethoxicarconyl
aminobenzena
amino
compounds
Prior art date
Application number
IDW990520A
Other languages
English (en)
Indonesian (id)
Inventor
Peter Meisel
Karl-Friedrich Landgraf
Jurgen Schafer
Wilfried Thiel
Matthias Rischer
Alfred Olbrich
Bernhard Kutscher
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of ID22645A publication Critical patent/ID22645A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDW990520A 1997-01-20 1998-01-09 Modifikasi terbaru untuk 2-amino-4-(4-fluorobenzilamino)-1-etoksikarbonil-aminobenzena dan proses-proses untuk membuat senyawa tersebut ID22645A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19701694A DE19701694A1 (de) 1997-01-20 1997-01-20 Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ID22645A true ID22645A (id) 1999-12-02

Family

ID=7817756

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990520A ID22645A (id) 1997-01-20 1998-01-09 Modifikasi terbaru untuk 2-amino-4-(4-fluorobenzilamino)-1-etoksikarbonil-aminobenzena dan proses-proses untuk membuat senyawa tersebut

Country Status (31)

Country Link
US (2) US5914425A (ja)
EP (1) EP0956281B1 (ja)
JP (1) JP4138886B2 (ja)
CN (1) CN1125812C (ja)
AR (1) AR015349A1 (ja)
AT (1) ATE222235T1 (ja)
AU (1) AU730776B2 (ja)
BG (1) BG63893B1 (ja)
BR (1) BR9806784A (ja)
CA (3) CA2632585C (ja)
CZ (1) CZ301778B6 (ja)
DE (2) DE19701694A1 (ja)
DK (1) DK0956281T3 (ja)
EG (1) EG21239A (ja)
ES (1) ES2178152T3 (ja)
HK (1) HK1024230A1 (ja)
HU (1) HU227625B1 (ja)
ID (1) ID22645A (ja)
IL (1) IL130384A (ja)
IS (1) IS2115B (ja)
NO (2) NO311642B1 (ja)
NZ (1) NZ336205A (ja)
PL (1) PL195956B1 (ja)
PT (1) PT956281E (ja)
RU (1) RU2186765C2 (ja)
SK (1) SK285303B6 (ja)
TR (1) TR199901674T2 (ja)
TW (1) TW531527B (ja)
UA (1) UA63937C2 (ja)
WO (1) WO1998031663A1 (ja)
ZA (1) ZA98319B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI287984B (en) 2000-10-17 2007-10-11 Wyeth Corp Pharmaceutical composition for modulating bladder function
US6589986B2 (en) 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders
AU2002338333A1 (en) * 2001-04-04 2002-10-21 Wyeth Methods for treating hyperactive gastric motility
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US20080045534A1 (en) * 2006-08-18 2008-02-21 Valeant Pharmaceuticals North America Derivatives of 1,3-diamino benzene as potassium channel modulators
PT2061465E (pt) * 2006-08-23 2013-07-15 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8030518B2 (en) * 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
WO2010009433A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
DE102009013612A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Retigabin-Tabletten, bevorzugt mit modifizierter Freisetzung
DE102009013611A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Festes Retigabin in nicht-kristalliner Form
DE102009013613A1 (de) 2009-03-17 2010-09-23 Ratiopharm Gmbh Trockenverarbeitung von Retigabin
WO2011039369A2 (en) 2009-10-02 2011-04-07 Medichem S.A. Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative
KR20120118012A (ko) 2010-01-20 2012-10-25 글락소 그룹 리미티드 신규의 레티가빈 조성물
EP2536394A2 (en) * 2010-02-19 2012-12-26 Medichem S.A. Stabilized phenylcarbamate derivative in solid state
CN202095728U (zh) 2010-10-29 2012-01-04 假日集团控股有限公司 行李箱把手
CN102464233A (zh) * 2010-11-18 2012-05-23 江苏邦威机械制造有限公司 一种卧式差速缠丝机用应力发生装置
JP2014510714A (ja) 2011-01-18 2014-05-01 グラクソ グループ リミテッド レチガビンの製造方法
CN102241608A (zh) * 2011-05-12 2011-11-16 天津市汉康医药生物技术有限公司 瑞替加滨化合物及其组合物
WO2013008250A2 (en) * 2011-07-01 2013-01-17 Dr.Reddys Laboratories Limited. Crystalline form of retigabine and processes for mixture of retigabine crystalline modifications
WO2013011518A1 (en) 2011-07-21 2013-01-24 Arch Pharmalabs Limited Process for the preparation of retigabine of the formula i and pharmaceutically acceptable salts thereof
CN102531966B (zh) * 2011-12-23 2013-07-24 山东创新药物研发有限公司 瑞替加滨的晶型d及其制备方法
WO2013114379A1 (en) * 2012-01-30 2013-08-08 Symed Labs Limited Novel polymorphs of n-[2-amino-4-(4-fluorobenzylamino)-phenyl] carbamic acid ethyl ester and processes thereof
CN103373941B (zh) * 2012-04-11 2016-08-17 浙江九洲药物科技有限公司 瑞替加滨及其中间体的制备方法
WO2013179298A2 (en) * 2012-04-23 2013-12-05 Cadila Healthcare Limited A process for preparation of phenyl carbamate derivative and polymorphic forms thereof
WO2014023270A1 (en) 2012-08-09 2014-02-13 Zentiva, K.S. Salts or co-crystals of ethyl n-[2-amino-4-[(4-fluorophenyl)methylamino]-phenyl]carbamate
CN102964273B (zh) * 2012-12-06 2014-04-02 北京英科博雅科技有限公司 瑞替加滨的新晶型f及其制备方法
USD773819S1 (en) 2015-05-27 2016-12-13 Travelpro Products, Inc. Handle for luggage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung

Also Published As

Publication number Publication date
NO311642B1 (no) 2001-12-27
HU227625B1 (en) 2011-09-28
NO993452L (no) 1999-07-13
TW531527B (en) 2003-05-11
DE19701694A1 (de) 1998-07-23
NZ336205A (en) 2000-01-28
ZA98319B (en) 1998-05-07
PL335647A1 (en) 2000-05-08
NO993452D0 (no) 1999-07-13
EP0956281A1 (de) 1999-11-17
HK1024230A1 (en) 2000-10-05
CA2634811C (en) 2012-11-20
CZ301778B6 (cs) 2010-06-23
JP4138886B2 (ja) 2008-08-27
PL195956B1 (pl) 2007-11-30
BR9806784A (pt) 2000-05-02
DK0956281T3 (da) 2002-11-04
CA2634811A1 (en) 1998-07-23
CA2278201C (en) 2009-06-16
ATE222235T1 (de) 2002-08-15
CA2632585C (en) 2010-08-24
WO1998031663A1 (de) 1998-07-23
AU730776B2 (en) 2001-03-15
JP2001508077A (ja) 2001-06-19
IS2115B (is) 2006-06-15
EP0956281B1 (de) 2002-08-14
UA63937C2 (uk) 2004-02-16
CZ250899A3 (cs) 1999-11-17
BG63893B1 (bg) 2003-05-30
CA2632585A1 (en) 1998-07-23
TR199901674T2 (ja) 1999-10-21
PT956281E (pt) 2002-12-31
SK95699A3 (en) 2000-03-13
RU2186765C2 (ru) 2002-08-10
EG21239A (en) 2001-03-31
US6538151B1 (en) 2003-03-25
CN1243506A (zh) 2000-02-02
IL130384A0 (en) 2000-06-01
IL130384A (en) 2003-02-12
CN1125812C (zh) 2003-10-29
HUP0000944A3 (en) 2000-10-30
ES2178152T3 (es) 2002-12-16
AU6208198A (en) 1998-08-07
IS5098A (is) 1999-06-29
NO2011017I1 (no) 2011-09-26
US5914425A (en) 1999-06-22
CA2278201A1 (en) 1998-07-23
SK285303B6 (sk) 2006-10-05
NO2011017I2 (no) 2013-04-02
AR015349A1 (es) 2001-05-02
HUP0000944A2 (hu) 2000-09-28
DE59805186D1 (de) 2002-09-19
BG103657A (en) 2000-02-29

Similar Documents

Publication Publication Date Title
ID22645A (id) Modifikasi terbaru untuk 2-amino-4-(4-fluorobenzilamino)-1-etoksikarbonil-aminobenzena dan proses-proses untuk membuat senyawa tersebut
ID25548A (id) Senyawa-senyawa heterosiklik spiroazabisiklik terbaru
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
NO2010022I2 (no) Denosumab
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
MX208461B (es) Polisacaridos de termofraguado
ID22850A (id) Senyawa-senyawa pirazina
NO994877D0 (no) Kalsilytiske forbindelser
DE59802830D1 (de) Orthesengelenk
BR9801679A (pt) Compostos de trianilaminoestilbeno
DE69803971D1 (de) Kraftfahrzeuggenerator-Gleichrichteranordnung
ID23803A (id) Turunan-turunan 2-(4-aril atau heteroaril-piperazin-1-ilmetil)-1h-indola
EE9900448A (et) Ühendid
NO995844D0 (no) Lumino/merkede polymerer for behandling av industrielle systemer
FI973171A0 (fi) Foerfarande foer drift av arbetsfartyg
DE69804744D1 (de) Metallbearbeitungsverfahren
DE69840366D1 (de) System zur probeentnahme
NO995404D0 (no) Forbindelser
ID22983A (id) Senyawa-senyawa fluorometoksimino
NO996544D0 (no) Forbindelser
EE9900466A (et) Ühendid